Adaptimmune Therapeutics PLC reports results for the quarter ended in June - Earnings Summary

Adaptimmune Therapeutics

12/08/2024 16:08

* Adaptimmune Therapeutics PLC  ADAP.OQ  reported quarterly
adjusted earnings of 24 cents​​ per share for the quarter ended
in June, higher than the same quarter last year, when the
company reported EPS of -23 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 7 cents per
share. Wall Street expected results to range from -20 cents to 7
cents per share.
    * Revenue rose 2,399.6% to $128.23 million from a year ago;
analysts expected $45.32 million. 
    * Adaptimmune Therapeutics PLC's reported EPS for the
quarter was
24 cents​.
    * The company reported quarterly net income of $69.52
million.
    * Adaptimmune Therapeutics PLC shares had risen by 1.8% this
quarter and gained 25.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 18.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Adaptimmune
Therapeutics PLC is $2.00 
This summary was machine generated from LSEG data August 12 at
03:07 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.07          0.24           Beat
 Mar. 31 2024      -0.10          -0.18          Missed
 Dec. 31 2023      -0.10          -0.24          Missed
 Sep. 30 2023      -0.14          -0.20          Missed